Phathom Pharmaceuticals, Inc. Common Stock (PHAT) is a publicly traded Healthcare sector company. As of May 20, 2026, PHAT trades at $11.83 with a market cap of $908.42M and a P/E ratio of -3.77. PHAT moved +0.18% today. Year to date, PHAT is -27.43%; over the trailing twelve months it is +159.68%. Its 52-week range spans $2.21 to $19.50. Analyst consensus is strong buy with an average price target of $24.25. Rallies surfaces PHAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Phathom Pharmaceuticals, Inc. Common Stock (PHAT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PHAT moved +0.18% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $11.83 |
| Market Cap | $908.42M |
| P/E Ratio | -3.77 |
| EPS | $-3.03 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.50 |
| 52-Week Low | $2.21 |
| Volume | 629 |
| Avg Volume | 0 |
| Revenue (TTM) | $175.11M |
| Net Income | $-221.25M |
| Gross Margin | 87.09% |
6 analysts cover PHAT: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.25.